Vectical Approval History
FDA Approved: Yes (First approved January 23, 2009)
Brand name: Vectical
Generic name: calcitriol
Dosage form: Ointment
Company: Galderma Laboratories, L.P.
Treatment for: Psoriasis
Vectical Ointment is a Vitamin D analog indicated for the topical treatment of mild to moderate plaque psoriasis in adults 18 years and older.
Development History and FDA Approval Process for Vectical
|Feb 3, 2009||Galderma Wins FDA Approval for Vectical Ointment, a Novel Topical Therapy for Mild-to-Moderate Plaque Psoriasis|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.